PRAMIPEXOLE GxP pramipexole dihydrochloride 0.25 mg tablets blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

pramipexole dihydrochloride monohydrate, Quantity: 0.25 mg

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

INN (International Nazwa):

pramipexole dihydrochloride monohydrate

Forma farmaceutyczna:

Tablet, uncoated

Skład:

Excipient Ingredients: mannitol; pregelatinised maize starch; magnesium stearate; povidone; silicon dioxide

Droga podania:

Oral

Sztuk w opakowaniu:

10, 30, 100

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.

Podsumowanie produktu:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '3' on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Licence status A

Data autoryzacji:

2014-09-23